DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
debdnp.bsky.social
DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
@debdnp.bsky.social
Love my family, nature, and the good in people. Nurse practitioner trying to make a difference in the lives of the Appalachian cardiovascular underserved. My opinions are not medical advice. #WVU, #Duke #Hopkins alumni #ACCCVT
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
Have you heard? ACC Committee applications are open! Visit the portal to review the 300➕ leadership roles across more than 80 ACC Committees.

✔️ #ACCFIT Section Leadership Council
✔️ #NCDR
✔️ #ACCAccreditation
✔️ More!

Find your fit and apply by Sept. 4 ➡️ https://bit.ly/3HrKw6B #ACCLeadership
August 24, 2025 at 2:08 AM
Great study reviews by @erictopol.bsky.social
A major paper @nature.com this week found a significant decline in dementia after an outdated Shingles vaccine.
I've reviewed the study and many other relevant ones here
erictopol.substack.com/p/the-shingl...
The Shingles Vaccine and Reduction of Dementia
A compelling new study adds to the body of data supporting some protection provided by the vaccine
erictopol.substack.com
April 5, 2025 at 11:03 PM
Another great session treating #cardiovasculardisease #diabetes. If you missed it, be sure to watch on demand. Excellent session with real world application. @accintouch.bsky.social #ACC.25
March 30, 2025 at 9:32 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
The STRIDE trial demonstrated that semaglutide significantly improves function, symptoms, and health-related QoL in patients with symptomatic #cvPAD and T2DM.

Get the full clinical trial details here ➡️ bit.ly/42dnA1n #ACC25 #CardioSky #MedSky
Exciting! #STRIDE trial just presented at #ACC25 @accintouch.bsky.social . #Semaglutide improved mean walking distance, symptoms, major limb events & quality of life in patients with #T2D & #PAD. We have a new drug now to help PAD patients! #CardioSky
March 29, 2025 at 4:02 PM
Amazing leaders in innovation on one stage @accintouch.bsky.social #ACC.25
March 29, 2025 at 8:39 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
The use of an SGLT2 inhibitor drug improved outcomes in patients undergoing TAVI (transcatheter aortic valve implantation). A randomized, placebo-controilled trial of 620 patients with high risk
www.nejm.org/doi/full/10....
#ACC25 @nejm.org
March 29, 2025 at 6:39 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
Extended anticoagulant therapy with reduced-dose apixaban was noninferior to full-dose in patients with active cancer and #cvVTE, based on findings from the API-CAT trial presented at #ACC25.

Read the journal scan to learn more: bit.ly/43w2A8v

#CardioSky #MedSky
March 29, 2025 at 4:28 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
DOACs significantly lower ischaemic stroke risk in atrial fibrillation patients post-intracerebral haemorrhage, but increase bleeding risk.

by Veltkamp R, Korompoki E (...) Heuschmann PU et 48 al. in Lancet #MedSky

📖 read the article: https://linkinghub.elsevier.com/retrieve/pii/S0140673625003332
March 7, 2025 at 6:36 PM
As someone who cares for #rural #underserved the challenges are real. Limited #access long waits for specialty care.2 hour or longer drive #Familytraditions #diet #lackofexercise #tobacco #vape. Thanks @jaccjournals.bsky.social for illuminating issues #cardiosky @accintouch.bsky.social #ACCCVT
January 31, 2025 at 10:44 PM
Great read and reminder
Should I use benzonatate (Tessalon Perles®) to treat cough?
January 27, 2025 at 2:07 AM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
3/4 PulseCheck Podcast #Palliative Cardiology series - #ACCGeriatric collab with #ACCCVT and the 🤩@andreaprice-317.bsky.social
High Risk Procedures in Our High Risk Patients

@christycantey.bsky.social Gwen Bernacki and Rich Josephson - so much wisdom here!

www.acc.org/latest-in-ca...
ACC CardiaCast: PulseCheck: Palliative Care in Patients with Heart Disease: High-Risk Procedures in Our High-Risk Patients - American College of Cardiology
www.acc.org
January 25, 2025 at 5:16 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
Managing GLP-1 RA GI-related adverse effects - Common question, new review. Some new tips for your patients. #diabetes, #obesity, #GLP-1RA

www.dovepress.com/dietary-reco...
December 28, 2024 at 4:12 PM
Well deserved Congratulations @garimasharmamd.bsky.social
December 22, 2024 at 11:06 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
#CardioSky peeps: @worldheart.org is now where the skies are blue!

Follow them for a global perspective on advocacy!
December 12, 2024 at 5:20 PM
Appalachian sunrises and sunsets. I am so lucky to call it home.
December 8, 2024 at 12:55 AM
My visitors today. Ironic they showed up after #Thanksgiving They are safe with me, I counted 10 wild turkeys #plantbaseddiet #AlmostHeaven
November 30, 2024 at 4:35 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
We used to hear the term "tired blood." [Geritol]
Now it's tired proteins. Proteolethargy. Reduced protein mobility as an underpinning for chronic diseases
www.cell.com/cell/abstrac...
November 27, 2024 at 7:39 PM
Congratulations! Happy to have great physicians #UVA in cardiology I rest easy knowing my patients have the best care!
Excited to announce that James McNamara MD of UTSW, former UVA student, will be joining the UVA CV Division in June '25 as Assoc. Director of the Echo Lab and member of the HCM COE. Welcome home James! #CardioSky
November 22, 2024 at 8:17 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
Another negative study about #vitD supplements in older adults, by @spjuraschek.bsky.social & colleagues from the STURDY trial. #CardioSky
Explore the article: "Effects of Vitamin D Supplementation on Cardiac Biomarkers: Results from the STURDY Trial." 🌞💊 Gain insights into the findings here: www.sciencedirect.com/science/arti... 🫀📚 #AJPC @aspcardio.bsky.social
November 21, 2024 at 8:24 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
MEGA PDF on Incretin therapies by the one and only @drkevinfernando.bsky.social
Very topical at the moment for CRM world
#PharmSky #Medsky #GPsky #CRM #CardioSky
img.medscapestatic.com/vim/live/pro...
November 19, 2024 at 7:03 PM
Reposted by DebCroy DNP ANP-BC AGPCNP-BC CLS FACC
So exciting! #SUMMIT trial, the first #HFpEF trial of incretin therapy with HF clinical outcomes as prespecified primary outcome. And #tirzepatide reduced CV death or worsening HF by significant 38%! Improvement in KCCQ quality of life by 7 pts, wt loss 12%, hsCRP reduction by 35%! #AHA24 #CardioSky
November 16, 2024 at 3:19 PM
Don't forget to register for the #ACC.25 Scientific Sessions in Chicago! Today is the last day for early bird registration @vietheartpa.bsky.social @jaepattonnp.bsky.social @erinmichos.bsky.social
Hi #CardioSky friends! 🌟 Tag us in your posts and let's work together to transform cardiovascular care and improve heart health for all 💖. Be sure to check out our journals too – give them a follow at @jaccjournals.bsky.social. 🦋
November 20, 2024 at 11:48 PM